Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study

2012 ◽  
Vol 28 (10) ◽  
pp. 1617-1634 ◽  
Author(s):  
Michael A. Überall ◽  
Gerhard H.H. Mueller-Schwefe ◽  
Bernd Terhaag
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Chronic Low Back Pain ◽  
Low Back ◽  
Modified Release ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Parallel Group ◽  
Phase Iv

scholarly journals Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

Pain ◽  
2020 ◽  
Vol 161 (9) ◽  
pp. 2068-2078 ◽  
Author(s):  
John D. Markman ◽  
Robert B. Bolash ◽  
Timothy E. McAlindon ◽  
Alan J. Kivitz ◽  
Manuel Pombo-Suarez ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Chronic Low Back Pain ◽  
Low Back ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document